AJOG MFM/LinkedIn
Dec 26, 2025, 13:09
Postpartum Readmission Rates Linked to Antihypertensive Choice – AJOG MFM
American Journal of Obstetrics and Gynecology MFM – AJOG MFM shared a post on LinkedIn:
“In a retrospective cohort of individuals with hypertensive disorders of pregnancy, discharge with labetalol rather than nifedipine was independently associated with increased risk of postpartum hospital readmission (9.2% vs 3.9%, P<.001).
Read the full text here.”
Title: Postpartum health-care utilization and blood pressure control by antihypertensive agent in hypertensive disorders of pregnancy
Authors: Carrie Bennett, Lara Lemon, Kripa Venkatakrishnan, Sanjana Ghosh, Hyagriv Simhan, Alisse Hauspurg
Stay updated on all scientific advances in the field of fertility with Fertility News.
-
Apr 15, 2026, 16:38Why an Ovulation Trigger Shot Sometimes Fails – Fertility Plus
-
Apr 15, 2026, 16:3374 New Studies Added to the AC Forum Literature Library – Anticoagulation Forum
-
Apr 15, 2026, 16:23Insights from PGT-A in Recurrent IVF Failure – Motherhood Training Center
-
Apr 15, 2026, 16:20Effect of Endometriosis and Adenomyosis on Oocyte Quality and Morphology – RBMO
-
Apr 15, 2026, 11:37Ally Murji: Honoured to be Part of the Canadian Session at the SEUD Meeting
-
Apr 15, 2026, 11:00Scammers are Targeting ESHRE2026 Attendees With Fake Registration and Hotel Offers – ESHRE
-
Apr 15, 2026, 10:24Join Us This Friday for Our “Research in Progress” – SRF
-
Apr 15, 2026, 10:20The Importance of Fertility Preservation in Turner Syndrome – RBMO
-
Apr 15, 2026, 10:16Marlena Fejzo: Our Study Identifying 6 New Genes Associated with Hyperemesis Gravidarum